Microbiology Department, University Hospital Vall d’Hebrón, Barcelona, Spain
Research Article
Leishmaniasis in a Patient with Fingolimod-Treated Multiple Sclerosis: Infectious Challenges of Disease Modifying Therapies
Author(s): Lopez-Gonzalez A, Bosch-Nicolau P, Rodriguez-Acevedo B, Zabalza A, Sulleiro E, Aznar ML and Sanchez-Montalva A
In this report, we present a case of visceral leishmaniasis in a patient with multiple sclerosis (MS) under fingolimod treatment. We discuss the previously published cases of MS patients under different immunosuppressant therapies to highlight its risk in endemic areas and suggest a therapeutic approach... View More»